Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm receives feedback from US FDA on ind submission

Sep 27, 2021 at 2:43 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment